PDE5A and pulmonary arterial hypertension: Approved drugs for PAH can be classified into 4 classes: prostacyclin analogs, endothelin-receptor antagonists (ERAs), phosphodiesterase type 5 (PDE-5) inhibitors and soluble guanylate cyclase (sGC) stimulators.